Q2 2026 Holdings
Filed 2026-08-11 | 463 holdings | $429.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $321.7K | 42,220 | 0.1% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $323.9K | 55,741 | 0.1% |
| Nuveen Churchill Direct Lend(NCDL) | COM SHS | 67090S108 | $325.2K | 26,180 | 0.1% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $328.6K | 18,258 | 0.1% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $330.6K | 10,576 | 0.1% |
| Ares Capital Corp(ARCC) | COM | 04010L103 | $335.0K | 18,080 | 0.1% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $336.3K | 3,549 | 0.1% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $338.1K | 108,703 | 0.1% |
| Summit Therapeutics Inc(SMMT) | COM | 86627T108 | $340.3K | 23,355 | 0.1% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $340.5K | 49,202 | 0.1% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $340.9K | 17,507 | 0.1% |
| Ares Dynamic CR Allocation F(ARDC) | COM | 04014F102 | $342.5K | 27,117 | 0.1% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $342.5K | 80,789 | 0.1% |
| Gladstone Invt Corp(GAIN) | COM | 376546107 | $343.6K | 22,223 | 0.1% |
| BlackRock Income TR Inc(BKT) | COM NEW | 09247F209 | $346.5K | 32,326 | 0.1% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $348.5K | 74,874 | 0.1% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $352.0K | 4,812 | 0.1% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $353.0K | 161,181 | 0.1% |
| Immatics N.v(IMTX) | SHS | N44445109 | $353.4K | 34,882 | 0.1% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $353.6K | 11,244 | 0.1% |
| BlackRock LTD Duration Incom(BLW) | COM SHS | 09249W101 | $354.3K | 28,365 | 0.1% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $355.1K | 8,521 | 0.1% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $358.2K | 172,209 | 0.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $358.7K | 43,166 | 0.1% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $359.0K | 10,973 | 0.1% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $359.1K | 25,111 | 0.1% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $359.6K | 4,050 | 0.1% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $360.0K | 7,093 | 0.1% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $362.4K | 51,045 | 0.1% |
| Eaton Vance Floating Rate in(EFT) | COM | 278279104 | $364.4K | 33,745 | 0.1% |
| Adlai Nortye LTD(ANL) | SPONSORED ADS | 00704R109 | $364.6K | 31,705 | 0.1% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $364.8K | 10,763 | 0.1% |
| Belite BIO Inc(BLTE) | SPONSORED ADS | 07782B104 | $364.8K | 2,369 | 0.1% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $367.6K | 20,012 | 0.1% |
| Pharvaris N V(PHVS) | COM | N69605108 | $368.3K | 10,651 | 0.1% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $368.7K | 76,807 | 0.1% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $370.6K | 24,130 | 0.1% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $370.7K | 424,933 | 0.1% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $371.2K | 53,638 | 0.1% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $371.5K | 10,806 | 0.1% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $372.2K | 10,714 | 0.1% |
| Climb BIO Inc(CLYM) | COM | 28658R106 | $373.0K | 28,602 | 0.1% |
| Morgan Stanley Direct Lendin(MSDL) | COM SHS | 61774A103 | $373.0K | 24,668 | 0.1% |
| First Tracks Biotherapeutics(TRAX) | ORD SHS | 337185102 | $373.2K | 18,549 | 0.1% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $373.7K | 11,513 | 0.1% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $373.8K | 13,853 | 0.1% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $374.3K | 9,606 | 0.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $375.0K | 9,732 | 0.1% |
| Immunome Inc(IMNM) | COM | 45257U108 | $377.2K | 17,802 | 0.1% |
| SLR Investment Corp(SLRC) | COM | 83413U100 | $377.9K | 30,547 | 0.1% |